NASDAQ$HLVX

HilleVax Inc · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

HilleVax reported Q4 2024 a net loss of $33.9M.

For Q4 2024, HilleVax reported net loss was $33.9M. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Net loss $33.9M.
  • MD&A highlights operating priorities, liquidity, and sector risks.
  • MD&A highlights operating priorities, liquidity, and sector risks.

Headline financials

Total Revenue

$0.00

Previous: $2.86M-100.0%
EPS (adj)

-$0.68

Previous: -$0.78+12.8%
Research and Development Expenses

$9.2M

No prior period
General and Administrative Expenses

$6.14M

No prior period
Total Operating Expenses

$36.2M

No prior period
Total Other Income, Net

$2.2M

No prior period
Weighted-Average Shares Outstanding

49.6M

No prior period
Net Income

-$33.9M

Previous: -$37M+8.4%
Operating Income

-$36.2M

Previous: -$40.3M+10.3%

Revenue & EPS history

HilleVax · Revenue · Quarterly

$0

Q4 2024-100%vs Q4 2023

Forward guidance

Outlook emphasizes milestones, liquidity runway, and cost discipline.

Tailwinds

  • Pipeline progress and partnership economics.
  • Cash supports near-term operating plans.

Headwinds

  • Operating losses until commercial scale.
  • Financing and competition affect funding costs.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 6 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

-3.3%

Avg return

Earnings day

-2.3%

Avg return

5 days after

-0.9%

Avg return

30 days after

22%

4 / 18 earnings

Positive

+7.9%

Q4 2024

Best reaction

-16.7%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025
Q2 2025+0.5%+0.5%+2.0%
Q1 2025-1.0%-5.6%-6.7%
Q4 2024+7.9%-10.1%+17.0%
Q3 2024-2.6%+1.6%+2.6%
Q2 2024-0.6%+5.7%+8.2%
Q1 2024+2.7%-3.0%+0.2%
Q4 2023-9.0%-5.4%-29.5%
Q3 2023+1.5%
Q2 2023-16.7%
Q1 2023-1.2%
Q4 2022-12.1%
Q3 2022-8.2%
Q3 2021-8.2%
Q2 2021-6.5%
Q2 2022-6.5%
Q1 2022+0.0%
Q1 2021+0.0%
Q4 2021+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro